Injective launches Trench Treasury as Canary files SEC ETF – Details

In a major boost for Injective, Canary Capital filed with the SEC for a staked INJ ETF. The fund seeks to offer exposure to Injective, less the expenses of the trust’s operations and other liabilities.

Also, the trust aims to earn additional INJ through its active participation in the staking program. The ETF is expected to launch before 2027, according to Injective’s CEO, Erick Chen.

If approved by the SEC, the ETF positions INJ to greater institutional exposure, especially now that spot ETFs have gained momentum.

Injective Foundation launches Trench Treasury

In addition to the upcoming ETF, Injective is seeking to expand its market influence to small builders. The Injective Foundation launched the Trench Treasury to fund projects and communities that help the ecosystem grow.

The initiative will help projects with organic growth, fair launches, real liquidity, and rewards for loyal ninjas in the ecosystem. What makes the step unique is that it will help smaller teams build with Injective, not just established projects.

The Trench Treasury has two goals. First, to back builders who are genuinely building with INJ. Secondly, to create ways to reward individuals who have contributed to ecosystem growth.

Most importantly, the Trench Treasury is not a fund for more projects but a way to encourage builders to build something new.

Can these developments help in demand recovery?

Incentivized by these two developments, investors have increased capital deployment. On the spot side, for example, Injective’s Spot Netflow dropped to -$1.12 million.

This marked a reversal from the positive zone recorded the previous day. The same capital flow pattern was observed in perpetuals.

Injective’s Perpetual Volume rose to $54 million from $53 million the previous day. The rising flows into perps suggested renewed interest in leveraged positions.

Historically, recovering demand across the market has also helped pave the way for better chart performance.

What’s next?

Structurally, Injective’s momentum is relatively weak. The altcoin has continued to hover between $7.5 and $7.7.

Amid this consolidation, the momentum indicators have leaned bearish. The altcoin’s Moving Average Convergence Divergence (MACD) has been on a downward trajectory since forming a bearish crossover a week ago.

Additionally, Stochastic (Stoch) also formed a bearish crossover, validating the market’s weakness. These two indicators suggest that downside pressure is strong and the trend is likely to continue.

Thus, if the momentum continues, Injective could breach $7.5 and revisit $7.1. However, if the Staked ETF and Trench Treasury incentivize buyers to return, thereby sustaining demand, they could clear the $7.7 resistance and move above $8.

Final Summary

• Injective Foundation launched the Trench Treasury to help projects with organic growth, fair launches, real liquidity, and rewards for loyal ninjas in the ecosystem.
• Canary Capital filed with the SEC for a staked INJ ETF, which is likely to launch before 2027.